HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anas Younes Selected Research

N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamide

6/2011Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor.
11/2010The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Anas Younes Research Topics

Disease

70Hodgkin Disease (Hodgkin's Disease)
01/2016 - 01/2002
47Neoplasms (Cancer)
01/2016 - 03/2002
42Lymphoma (Lymphomas)
11/2015 - 12/2002
28Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2014 - 09/2003
11Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2012 - 12/2003
10Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2015 - 12/2003
7B-Cell Lymphoma (Lymphoma, B Cell)
06/2015 - 08/2003
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
03/2015 - 11/2010
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2012 - 03/2003
5Disease Progression
07/2012 - 03/2004
5Necrosis
03/2011 - 08/2003
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2015 - 05/2012
4Neutropenia
06/2015 - 07/2005
4Infection
12/2013 - 04/2005
3Hematologic Neoplasms (Hematological Malignancy)
11/2012 - 02/2008
3Leukemia
02/2012 - 10/2004
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2012 - 10/2004
2Fatigue
12/2013 - 12/2013
2Anemia
12/2013 - 07/2005
2Thrombocytopenia (Thrombopenia)
12/2013 - 11/2010
2Testicular Neoplasms (Testicular Cancer)
11/2011 - 10/2011
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2010 - 09/2010
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2004 - 08/2004

Drug/Important Bio-Agent (IBA)

20rituximab (Mabthera)FDA Link
01/2016 - 07/2003
16cAC10-vcMMAEIBA
01/2016 - 11/2010
14Doxorubicin (Adriamycin)FDA LinkGeneric
03/2015 - 12/2004
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 12/2004
8Vincristine (Oncovin)FDA LinkGeneric
11/2015 - 12/2004
7Prednisone (Sone)FDA LinkGeneric
03/2015 - 12/2004
6LBH589IBA
05/2014 - 09/2010
6Bleomycin (Blenoxane)FDA LinkGeneric
04/2014 - 11/2006
6fludarabineIBA
03/2012 - 12/2002
6Histone Deacetylase InhibitorsIBA
12/2011 - 09/2010
5Cytarabine (Cytosar-U)FDA LinkGeneric
11/2015 - 04/2005
5Methotrexate (Mexate)FDA LinkGeneric
11/2015 - 12/2003
5CytokinesIBA
05/2014 - 01/2005
5Dacarbazine (DIC)FDA LinkGeneric
04/2014 - 11/2006
5vorinostat (suberoylanilide hydroxamic acid)FDA Link
07/2013 - 04/2008
5Monoclonal AntibodiesIBA
09/2012 - 08/2005
517-(allylamino)-17-demethoxygeldanamycin (17AAG)IBA
05/2012 - 04/2005
5bortezomib (Velcade)FDA Link
07/2011 - 05/2004
5Proteins (Proteins, Gene)IBA
11/2010 - 08/2003
5Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2007 - 04/2005
4Dexamethasone (Maxidex)FDA LinkGeneric
11/2015 - 12/2002
4AntigensIBA
08/2012 - 01/2007
4Vinblastine (Vinblastine Sulfate)FDA Link
05/2012 - 11/2006
4Sirolimus (Rapamycin)FDA Link
11/2010 - 01/2006
4Proteasome Endopeptidase Complex (Proteasome)IBA
11/2010 - 05/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2008 - 08/2003
4AntibodiesIBA
01/2007 - 08/2005
4Phosphotransferases (Kinase)IBA
02/2006 - 08/2003
3Etoposide (VP 16)FDA LinkGeneric
03/2015 - 04/2005
3Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 03/2006
3InterferonsIBA
05/2012 - 07/2005
3gemcitabineFDA Link
03/2012 - 02/2008
3Melphalan (Alkeran)FDA LinkGeneric
03/2012 - 04/2005
3temsirolimusFDA Link
11/2010 - 04/2008
3galiximabIBA
01/2007 - 03/2003
3NF-kappa B (NF-kB)IBA
05/2004 - 01/2002
2pegylated liposomal doxorubicinIBA
11/2015 - 03/2015
2Pentostatin (Nipent)FDA LinkGeneric
06/2015 - 09/2003
2Topotecan (Hycamtin)FDA LinkGeneric
10/2014 - 03/2006
2Biological Markers (Surrogate Marker)IBA
10/2014 - 08/2014
2ChemokinesIBA
05/2014 - 10/2011
2Chemokine CCL17IBA
05/2014 - 10/2011
2everolimusFDA Link
12/2013 - 04/2012
2EnzymesIBA
01/2013 - 11/2009
2Immunoconjugates (Immunoconjugate)IBA
08/2012 - 01/2007
2Adenosine Triphosphate (ATP)IBA
07/2012 - 01/2012
2A-factor (Streptomyces)IBA
07/2012 - 08/2003
2N 30IBA
10/2011 - 03/2002
2N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)IBA
10/2011 - 09/2010
2Interleukin-12 (IL 12)IBA
10/2011 - 08/2004
2N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamideIBA
06/2011 - 11/2010
2Interleukin-10 (Interleukin 10)IBA
03/2011 - 08/2008
2romidepsin (FK228)FDA Link
11/2010 - 09/2010
2Cyclin D1IBA
04/2008 - 10/2006
2RANK LigandIBA
10/2007 - 09/2003
2VaccinesIBA
01/2007 - 08/2004
2anaplastic lymphoma kinaseIBA
12/2006 - 12/2003
2U 0126 (UO 126)IBA
12/2006 - 08/2003
2pegfilgrastim (Neulasta)FDA Link
11/2006 - 03/2006
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
03/2006 - 09/2003
2TNF-Related Apoptosis-Inducing LigandIBA
03/2006 - 09/2003
2Caspase 8 (Caspase-8)IBA
08/2005 - 08/2003
2Mitoxantrone (Novantrone)FDA LinkGeneric
07/2005 - 12/2002
2LigandsIBA
10/2004 - 09/2003
2CD40 Ligand (CD40L)IBA
09/2003 - 01/2002

Therapy/Procedure

30Drug Therapy (Chemotherapy)
06/2015 - 03/2002
19Stem Cell Transplantation
01/2016 - 12/2002
11Transplants (Transplant)
03/2015 - 02/2008
4Combination Drug Therapy (Combination Chemotherapy)
04/2014 - 09/2003
4Aftercare (After-Treatment)
12/2013 - 07/2005
3Radiotherapy
01/2003 - 03/2002
2Therapeutics
11/2015 - 11/2013
2Salvage Therapy
03/2015 - 11/2014
2Transplantation (Transplant Recipients)
03/2015 - 03/2006
2Intravenous Infusions
08/2012 - 08/2005
2Homologous Transplantation (Allograft)
02/2008 - 12/2003
2Investigational Therapies (Experimental Therapy)
10/2005 - 08/2004